Annual Accounts Payable
$11.99 M
+$3.17 M+35.86%
December 31, 2023
Summary
- As of February 8, 2025, ARQT annual accounts payable is $11.99 million, with the most recent change of +$3.17 million (+35.86%) on December 31, 2023.
- During the last 3 years, ARQT annual accounts payable has risen by +$4.85 million (+67.96%).
- ARQT annual accounts payable is now at all-time high.
Performance
ARQT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$19.32 M
+$11.38 M+143.30%
September 30, 2024
Summary
- As of February 8, 2025, ARQT quarterly accounts payable is $19.32 million, with the most recent change of +$11.38 million (+143.30%) on September 30, 2024.
- Over the past year, ARQT quarterly accounts payable has increased by +$6.15 million (+46.63%).
- ARQT quarterly accounts payable is now at all-time high.
Performance
ARQT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ARQT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.9% | +46.6% |
| 3 y3 years | +68.0% | +46.6% |
| 5 y5 years | +565.9% | +46.6% |
ARQT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.1% | at high | +162.8% |
| 5 y | 5-year | at high | +753.5% | at high | +1275.4% |
| alltime | all time | at high | +2133.2% | at high | +1275.4% |
Arcutis Biotherapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $19.32 M(+143.3%) |
| Jun 2024 | - | $7.94 M(-38.8%) |
| Mar 2024 | - | $12.97 M(+8.1%) |
| Dec 2023 | $11.99 M(+35.9%) | $11.99 M(-9.0%) |
| Sep 2023 | - | $13.18 M(-23.2%) |
| Jun 2023 | - | $17.16 M(+37.4%) |
| Mar 2023 | - | $12.48 M(+41.4%) |
| Dec 2022 | $8.83 M(+20.0%) | $8.83 M(+1.9%) |
| Sep 2022 | - | $8.67 M(+2.7%) |
| Jun 2022 | - | $8.44 M(-32.3%) |
| Mar 2022 | - | $12.47 M(+69.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $7.35 M(+3.0%) | $7.35 M(+51.0%) |
| Sep 2021 | - | $4.87 M(+82.0%) |
| Jun 2021 | - | $2.68 M(-14.9%) |
| Mar 2021 | - | $3.15 M(-55.9%) |
| Dec 2020 | $7.14 M(+408.2%) | $7.14 M(+41.7%) |
| Sep 2020 | - | $5.04 M(-38.9%) |
| Jun 2020 | - | $8.25 M(+73.4%) |
| Mar 2020 | - | $4.76 M(+238.7%) |
| Dec 2019 | $1.41 M(-22.0%) | $1.41 M(-55.5%) |
| Sep 2019 | - | $3.16 M(+75.4%) |
| Dec 2018 | $1.80 M(+235.4%) | $1.80 M |
| Dec 2017 | $537.00 K | - |
FAQ
- What is Arcutis Biotherapeutics annual accounts payable?
- What is the all time high annual accounts payable for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual accounts payable year-on-year change?
- What is Arcutis Biotherapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly accounts payable year-on-year change?
What is Arcutis Biotherapeutics annual accounts payable?
The current annual accounts payable of ARQT is $11.99 M
What is the all time high annual accounts payable for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual accounts payable is $11.99 M
What is Arcutis Biotherapeutics annual accounts payable year-on-year change?
Over the past year, ARQT annual accounts payable has changed by +$3.17 M (+35.86%)
What is Arcutis Biotherapeutics quarterly accounts payable?
The current quarterly accounts payable of ARQT is $19.32 M
What is the all time high quarterly accounts payable for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly accounts payable is $19.32 M
What is Arcutis Biotherapeutics quarterly accounts payable year-on-year change?
Over the past year, ARQT quarterly accounts payable has changed by +$6.15 M (+46.63%)